pharma stocks

Stock market recommendations: Mirae Asset Sharekhan suggests buying Aurobindo Pharma, anticipating a breakout from a flag pattern with a target of Rs 1356, and IRCTC, expecting an upward trend to Rs 802 after breaking consolidation.

Stock market today: The NSE Nifty decreased by 81.55 points (0.33%) to 24,379.60. The BSE Sensex fell 155.77 points (0.19%) to close at 80,641.07, after dropping 315.81 points (0.39%) to 80,481.03 during the session.

Stock market today: Indian equity benchmark indices, Nifty50 and BSE Sensex, swung between red and green on Wednesday. VK Vijayakumar, Chief Investment Strategist, Geojit Investments Limited says, "What stands out in “Operation Sindoor” from the market perspective is its focused and non-escalatory nature.

Stock market today: Stock market indices Nifty and Sensex ended slightly higher in volatile trading on Tuesday, with investors showing caution over geopolitical tensions.

Citigroup recommends buying Divis Laboratories, anticipating its rise as a key supplier. CLSA maintains a hold on Tata Consumer due to margin concerns. ICICI Securities holds LTIMindtree, citing muted performance. HSBC suggests reducing Bajaj Housing Finance due to cost pressures. Nomura recommends buying Anant Raj Industries despite a lowered target price.

The Enforcement Directorate (ED) is investigating the FairPlay betting app for illegally streaming IPL matches and laundering money. The investigation revealed that approximately Rs 13,000 crore was sent abroad under the guise of import payments through four firms. Celebrities endorsed the app, and a payment gateway processed Rs 3,000 crore in transactions.

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a cultural and medical shift. Its off-label use, fueled by celebrity endorsements and social media trends, has led to increased demand and supply shortages. While effective, Ozempic's health risks, regulatory challenges, and cultural impact are under scrutiny.

Indian pharmaceutical stocks experienced a downturn following Donald Trump's renewed threat to impose tariffs on pharmaceutical imports. The Nifty Pharma index fell by 1.7%, with major companies like Gland Pharma and Sun Pharma seeing significant declines. Trump's statement highlighted the intention to incentivize pharmaceutical companies to shift production to the US through tariffs, impacting India's substantial generic drug exports to the US.

Indian equity markets surged on Friday, mirroring a global rebound and fueled by value buying across sectors. The Sensex soared over 1244 points, while the Nifty 50 climbed more than 400 points, driven by positive domestic cues and expectations of steady inflation. Experts suggest long-term investors consider selective buying in financials and pharmaceuticals.

Dalal Street saw a significant decline as the escalating trade war caused investor sentiment to fall. US tariffs led to a 34% retaliatory tariff by China, resulting in a sharp decrease in sensex and Nifty, with intense selling affecting auto, metal, and pharma stocks.

A Russian missile struck a warehouse belonging to Kusum Healthcare, an Indian pharmaceutical company, in Ukraine, prompting condemnation from the Ukrainian embassy, which alleged a deliberate targeting of Indian businesses. While details on damage and casualties remain scarce, the incident has yet to elicit comment from the Indian or Russian governments.

Indian stock markets rallied as the US suspended additional tariffs on India. Sensex and Nifty witnessed significant gains in early trading. Tata Motors and Reliance Industries led the surge. Asian markets showed mixed trends. Investors are relieved by India's strong macroeconomic position amidst global trade tensions. Brent crude oil prices declined slightly. Foreign Institutional Investors had previously offloaded equities.

Indian stocks with significant US market exposure are facing heavy selling pressure amid growing recession fears in the US and a potential global slowdown. Concerns over high US import tariffs and retaliatory measures are impacting sectors like auto, metals, software, and pharma.

Stock market today: BSE Sensex and Nifty50, the Indian equity benchmark indices, rallied strongly in opening trade on Tuesday a day after the terrible stock market crash. While BSE Sensex went above 74,700, Nifty50 was above 22,600.

Stock market today: BSE Sensex and Nifty50, the Indian equity benchmark indices, closed in red on Wednesday taking cues from global markets. While BSE Sensex went below 73,700 intraday, Nifty50 dipped to near 22,350 levels.

In the coming truncated trading week, Dalal Street investors will focus on US tariff-related issues, RBI’s interest rate decision, and other key economic factors. The recent US tariffs have triggered a global market meltdown, with significant losses in major indices worldwide, impacting various sectors back home.